4,000 patients join landmark PBC study in china
NCT ID NCT07149675
First seen Nov 01, 2025 · Last updated May 22, 2026 · Updated 24 times
Summary
This study aims to better understand primary biliary cholangitis (PBC), a chronic liver disease, in Chinese patients. Researchers will track 4,000 participants over time to see how symptoms like fatigue and itching affect their lives and how well treatments work. The goal is to improve care and predict long-term outcomes for people with PBC.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PRIMARY BILIARY CHOLANGITIS (PBC) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Liver Research Center, Beijing Friendship Hospital, Capital Medical University
RECRUITINGBeijing, Select A State Or Province, 100069, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.